Live Breaking News & Updates on அறிவியல் நாஸ்டாக்

Stay updated with breaking news from அறிவியல் நாஸ்டாக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Five Innovative Stocks to Buy for Growth Industry Breakthroughs


Five Innovative Stocks to Buy for Growth Industry Breakthroughs
 Share
  Share
Five innovative stocks to buy give investors an opportunity to profit from advances occurring in growth industries.
Among the five innovative stocks to buy are the world’s largest lithium miner, the developer of a pharmaceutical to treat people suffering from post-traumatic stress disorder (PTSD), a cryptocurrency brokerage firm and two cancer treatment providers. The five innovative stocks to buy are the combined recommendations of two former Wall Street professionals who shared their picks during the recent Global Financial Summit held as part of the FreedomFest conference in Rapid City, South Dakota, drawing a record 2,700-plus attendees. ....

New York , United States , Los Gatos , United Kingdom , South Dakota , Palo Alto , Rapid City , Joe Theismann , Joe Montana , Jim Woods , Paul Dykewicz , Mark Skousen , Doug Drysdale , Reggie Brooks , Lou Holtz , Bob Carlson , Santa Clara , Alex Green , Dick Vitale , Kevin Conroy , Ara Parseghian , Square Inc , Centers For Disease , Johns Hopkins University , National Cancer Institute , Cybin Inc ,

It's Already Doubled in 2021, and This Healthcare Juggernaut Is Just Getting Started


Skin cancer detection company
Dermtech (NASDAQ:DMTK) has seen a spree of good news lately. The company is reimagining the way skin cancer is detected, using stickers rather than scalpels to remove cells for testing. With several factors pushing the stock to double so far this year, its ascent may be just beginning.
The clinical data for its melanoma detection sticker, which is called the Pigmented Lesion Assay (PLA), is promising, with the sticker demonstrating superiority to a traditional scalpel-wielding biopsy. Just how much better is it? Standard biopsies miss about 17% of melanoma cases; the PLA misses just 1%. It s also more efficient for every 25 biopsies performed, only one melanoma will be found, compared with one melanoma for every 2.7 PLA tests. All of this is a big win for patients but the positive news for this small cap doesn t stop there. ....

United States , Merritt Hawkins , Geisinger Health , National Comprehensive Cancer Network , Sciences Nasdaq , Pigmented Lesion Assay , Image Source , Blue Cross , Blue Shield , Geisinger Health Plans , Exact Sciences , ஒன்றுபட்டது மாநிலங்களில் , மெரிட் ஹாக்கின்ஸ் , கேய்சிங்கேர் ஆரோக்கியம் , தேசிய விரிவான புற்றுநோய் வலைப்பின்னல் , அறிவியல் நாஸ்டாக் , படம் மூல , நீலம் குறுக்கு , நீலம் கவசம் , கேய்சிங்கேர் ஆரோக்கியம் திட்டங்கள் , சரியான அறிவியல் ,